- Home
- UNH vs AZN Comparison
UNH vs AZN Comparison
Compare UNH & AZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UNH
- AZN
- Stock Information
- Founded
- UNH 1977
- AZN 1992
- Country
- UNH United States
- AZN United Kingdom
- Employees
- UNH N/A
- AZN N/A
- Industry
- UNH Medical Specialities
- AZN Biotechnology: Pharmaceutical Preparations
- Sector
- UNH Health Care
- AZN Health Care
- Exchange
- UNH Nasdaq
- AZN Nasdaq
- Market Cap
- UNH 279.9B
- AZN 228.9B
- IPO Year
- UNH 1984
- AZN 1993
- Fundamental
- Price
- UNH $281.08
- AZN $72.66
- Analyst Decision
- UNH Buy
- AZN Strong Buy
- Analyst Count
- UNH 24
- AZN 3
- Target Price
- UNH $424.52
- AZN $95.00
- AVG Volume (30 Days)
- UNH 13.2M
- AZN 4.2M
- Earning Date
- UNH 07-29-2025
- AZN 07-29-2025
- Dividend Yield
- UNH 3.15%
- AZN 2.09%
- EPS Growth
- UNH 44.67
- AZN 22.71
- EPS
- UNH 23.82
- AZN 4.97
- Revenue
- UNH $410,057,000,000.00
- AZN $54,982,000,000.00
- Revenue This Year
- UNH $13.42
- AZN $9.56
- Revenue Next Year
- UNH $6.38
- AZN $6.09
- P/E Ratio
- UNH $11.80
- AZN $28.96
- Revenue Growth
- UNH 8.06
- AZN 15.48
- 52 Week Low
- UNH $248.88
- AZN $61.24
- 52 Week High
- UNH $630.73
- AZN $87.68
- Technical
- Relative Strength Index (RSI)
- UNH 37.44
- AZN 57.29
- Support Level
- UNH $278.22
- AZN $68.61
- Resistance Level
- UNH $292.64
- AZN $74.38
- Average True Range (ATR)
- UNH 6.82
- AZN 1.03
- MACD
- UNH -0.68
- AZN 0.34
- Stochastic Oscillator
- UNH 9.51
- AZN 70.19
About UNH UnitedHealth Group
UnitedHealth Group is one of the largest private health insurers and provides medical benefits to about 51 million members globally, including 1 million outside the US as of December 2024. As a leader in employer-sponsored, self-directed, and government-backed insurance plans, UnitedHealth has obtained massive scale in medical insurance. Along with its insurance assets, UnitedHealth's Optum franchises help create a healthcare services colossus that spans everything from pharmaceutical benefits to providing outpatient care and analytics to both affiliated and third-party customers.
About AZN AstraZeneca PLC
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (about 40% of total revenue), cardiovascular, renal, and metabolic (25%), rare disease (17%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one third of its sales.